The problems related to the increasing prevalence of infectious multiple-drug resistance presently have serious implications on human health all over the world (9) . The infectious multiple-drug resistance is mediated by conjugative R (resistance) plasmids, which are extrachromosomal deoxyribonucleic acid molecules possessing genes generally determining the production of enzymes that are able to inactivate the effect of the antibiotics. The pathogenic enteric bacteria, which may become multiply resistant include the organisms that cause bacillary dysentery, typhoid fever, cholera, and plaque. R plasmids are particularly common in Shigella and Salmonella with frequencies of about 50% as reported from many countries (7, 9, 14, 21, 25) . The frequencies of R plasmids in the common enteric bacteria such as Escherichia coli, Proteus and Klebsiella presently seem to be at least 10 to 20% in populations at large (4, 9, 17, 24) and at least 20 to 30% in hospitals (1, 9, 17) .
Extrachromosomal-determined antibiotic resistance is also well known in Staphylococcus (18) and is currently reported in species within the genera Streptococcus (5, 16) , Haemophilus (11), Mycobacterium (13), Clostridium (19) , and Bordetella (23).
The R plasihid-mediated resistance is often, and presumably with increasing frequency, multiple, which means that the R plasmidcarrying bacteria are resistant to 3 to 5 or even more antibiotics. There are also some indications of an increasing frequency of multiple resistance in especially virulent strains (E. S. Anderson (9, 10, 26) . Certain antibiotics, notably tetracycline, have a great potential for selection of bacteria with R plasmid-determined drug resistance (8) . Such bacteria may also be resistant to other drugs than the one used for selection of the R plasmids (8) . The treatment of severe cases ofacne vulgaris with low doses of tetracycline for long periods is widely used and generally accepted to be without serious side effects (20) . In this paper, we report on the drug resistance patterns and the frequency of R plasmids in E. coli isolated from a group of otherwise healthy people that had been treated for different periods with low oral doses of tetracycline for a skin disease (acne vulgaris).
MATERIALS AND METHODS
Patients. All patients (88) were seen in the outpatient clinic at the Department of Dermatology, Marselisborg Hospital, Aarhus, for treatment with tetracycline ofacne vulgaris or rosacea. Apart from this treatment, none of the patients had been treated with antbiotics or had been admitted to a hospital for the last 6 months.
The treatment consisted of a single oral dose of tetracycline (250 to 500 mg/day) for the first 2 weeks. Thereafter, the dose generally was 250 mg/day. The patients were divided into four groups. One group consisted of patients (18) Resistance transfer. All resistant strains of E. coli were tested for transfer of resistance to the E. coli K-12 strain J53-1 according to methods described previously (17) . All the J53-1 strains were able to transfer their acquired resistance pattern to another recipient E. coli K-12 strain J 62-2. This was done separately for each marker ofthe resistance pattern.
RESULTS
The 88 patients were divided into four groups as described in Materials and Methods. The results are given in Tables 1, 2 , and 3. It is seen that the proportion ofpatients with resistant E. coli increases from 50% before treatment to 69% after 1 week of treatment, to 75% after 4 weeks, and to 88% in the group treated for more than 4 weeks. The figures for the frequencies of R plasmids in the resistant bacteria in the four groups were 63, 67, 75, and 83%. No multipleresistant E. coli (resistant to 3 or more antibiotics) was found in patients before or after 1 week of treatment. However, in the course of the treatment multiple-resistant E. coli could be isolated with increasing frequency (from 38% of the patients treated for 4 weeks and from 49% in the group treated for more than 4 weeks). Resistance against gentamicin and nalidixic acid did not occur among the strains investigated. The resistance patterns of these multiply drug-resistant bacteria were partially or completely transferable in 83 and 85% of the cases, respectively. The patterns of resistance transferred are shown in Table 3 .
A few points for explanation of the results are needed. It is known that some resistance plasmids are not self-transmissible. Because of that and limitations in the -method for determination of transfer, the figures for the fraction of resistant bacteria containing R plasmids are minimum values.
Although only semiquantitative methods are used, it seems safe to conclude that in patients treated for a few weeks or longer, the majority of the population of E. coli had the resistance pattern stated in Table 2 .
The rather unexpected finding of only susceptible E. coli in some of the patients treated for 4 weeks or longer needs an explanation. One would certainly have expected these bacteria to be resistant to tetracycline. It appeared however, that the majority of bacteria isolated in these cases were either mono-or multiple-resistant Proteus mirabilis or Streptococcus faecalis, while E. coli accounted for only a minor (1) Su (1) Tc (4) Tc (9) Tc (6) Tc (6) Tc-Su (1) Tc-Su (2) Tc-Su (1) Tc-Ap (2) Tc-Sm (1) Tc-Ap (3) Su-Sm (1) Tc-Su-Sm (4) Tc-Sm (3) Tc-Su-Sm-Ap (1) Tc-Su-Sm (10) Tc-Su-Sm-Cm-Ap (1) Tc-Su-Sm-Ap (2) Tc-Su-Cm-Ap (1) Tc-Su-Sm-Cm-Ap (3) Tc-Su-Tp-Sm-Ap (1) Tc-Su-Tp-Sm-Cm-Km (1) Tc-Su-Sm-Cm-Km-Ap (1) a Number in parentheses is number of patients.
b Tc = tetracycline, Su = sulfonamide, Tp = trimethoprim, Sm = streptomycin, Cm = chloramphenicol, Km = kanamycin, Ap = ampicillin, Nx = nalidixic acid, Gm = gentamicin. 
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b Tc = tetracycline, Su = sulfonamide, Tp = trimethoprim, Sm = streptomycin, Cm = chloramphenicol, Km = kanamycin, Ap = ampicillin, Nx = nalidixic acid, Gm = gentamicin.
fraction of the aerobic organisms in the intestines of these patients. DISCUSSION The results clearly illustrate that long-term tetracycline treatment has two main effects on the drug resistance of E. coli in the intestinal flora. One is the occurrence of an increasing frequency of R plasmid-determined resistance and the other is the progressive tendency for this resistance to be multiple.
It is known that tetracycline very effectively selects for R plasmid-determined resistance from studies of R plasmids in enteric bacteria from animals given tetracycline in their feed (9) and from patients treated for a shorter time (10 days) with tetracycline (2, 8, 12) . It is important to realize that the R plasmid-carrying bacteria, once selected to constitute the majority of the aerobic intestinal flora, disappear slowly only after withdrawal of the antibiotic treatment (2, 6) . It is also known that R plasmidcarrying bacteria are, to a great extent, disseminated to other people in the patient's environment (6) .
Although it has been reported that treatment with certain antibiotics such as tetracycline, may sometimes select for bacteria that are multiply resistant (8) , there is no obvious explanation why this should happen with the frequency and apparent regularity that was seen in this study. The fact implies that the additional resistance genes or other factors somehow make these bacteria more fit in an environment containing tetracycline than are bacteria with R plasmid-determined tetracycline resistance only. It must be remembered that multiply drug-resistant bacteria were not demonstrated at all in patients before or after 1 week of treatment, whereas bacteria with R plasmiddetermined tetracycline resistance were detected fairly often in these groups. Therefore, 390 MOLLER ET AL. the question is not only why the multiply drugresistant bacteria came to dominate, but also where they came from.
It is known that R plasmid-carrying bacteria are transferred to humans, either from food contaminated with animal bacteria (3), from other human beings directly (6), or via contaminated food or water (15, 25) . Before treatment, the patients may already harbor multiply drugresistant bacteria at a concentration below the detectability of the methods used, or they may acquire them during the treatment. A third possibility that might play a role in the development of the resistance patterns could be the transfer of drug resistance from the anaerobic bacteria that constitute the majority of the enteric bacteria in the bowel flora.
Finally, we wish to emphasize the need for an intensified research of the factors responsible for the increasing frequency ofbacteria that are multiply drug resistant. It is possible that only certain antbiotics, as shown here for tetracycline, have the ability for a preferential selection of multiple resistance. If this is true, a limitation in the use of these drugs should be recommended.
